1HU FB, MEIGS JB, LI TY, et al. Inflammatory markersand risk of developing type 2 diabetes in women[J]. Diabetes, 2004, 53(3) :693-700.
2SPRANGER J, KROKE A,MOHL IGM , et al. Inflammato-ry cytokines and the risk to develop type 2 di-abetes :results of the prespective populationbased European prospective investigation intocancer and nutrition(EP IC Potsdam study[J]. Dia-betes, 2003, 52(3) :812-817.
6CERIELL0 A, J0HNSD, WIDE LM, et al. Comparison ofeffect of pioglitazone with metformin or sulf-onylurea (monorherapy and combination therapy)onpost load glycose tolerance test in patients w-ith type 2 diabetes[J]. Diabetes Care,2005,28(2):266—272.
8GALL A ( CEL0TT0 G,PINT0N P, et al. Metformin pre-vents glucose-induced protein kinase-cbeta. Iac-tivation in human umbilical veinendothelial ce-lls through an anti oxidant mechanism[J]. Dia-betes, 2005,54(4) : 1123-1131.
二级参考文献48
1Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis. Circulation ,2003,107 ( 3 ) :398-404.
2Portik-Dobos V, Anstadt MP, Hutchinson J, et al. Evidence for a matrix metalloproteinase induction/activation system in arterial vascularture and decreased synthesis and activity in diabetes. Diabetes,2002,51 (10) :3036-3068.
3Haffner SM, Greenberg AS, Weston WM, et al. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation, 2002, 106(6) :679-684.
4Ross R. Atherosclerosis is an inflammatory disease. Am Heart J,1999,138(5 pt 2) :S419-420.
5Brand K, Page S, Kogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996,97 ( 7 ): 1715-1722.
6Erbagci AB,Tarakcioglu M, Coskun Y,et al. Mediators of inflammation in children with type Ⅰ diabetes mellitus: cytokines in type Ⅰ diabetic children. Clin Biochem,2001,34 ( 8 ) :645-650.
7Temaru R, Urakaze M, Satou A, et al. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia, 1997,40( 5 ) :610-613.
8Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactioe protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation,2001,103(21 ) :2531-2534.
9Verma S, Kuliszewski MA, Li SH, et al. C-reactioe protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between CRP and cardiovascular disease. Circulation,2004,109 ( 17 ) :2058-2067.
10Verma S,Wang CH,Li SH,et al. A self-fulfilling prophecy:C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 2002,106 ( 8 ) :913-919.
